The Importance Of Trade Secrets

Improved Essays
Assignment 4

Introduction

Intellectual property is intangible items such as computer software, a formula, any invention, and other items that an individual, university, or corporation claims they own (Shamoo & Resnik, 2009, p. 167). Therefore, there are different types of intellectual property rights that are recognized by the United States law (Shamoo & Resnik, 2009, p. 173). Consequently, laws pertaining to intellectual property rights have only been implemented since the 1980s, which these laws are of the Boyh-Dole Act of 1980 and the Technology Transfer Act of 1986 (Shamoo & Resnik, 2009, p. 170). As a result, intellectual property can have huge financial implications on healthcare research and pharmaceutical companies. Therefore,
…show more content…
Therefore, trade secrets are used to prevent information from becoming publicly known such as the secret recipe for Coca-Cola (Shamoo & Resnik, 2009, p. 177). There are a variety of items that are used for trade secrets such as instruments, specific business policies, customer lists, and business plans (Shamoo & Resnik, 2009, p. 177). There are few advantages for trade secrets to be used in health care research and/or pharmaceutical companies.
Trade Secrets: Advantages
A trade secret may be more useful than the other types of intellectual property rights. However, within the healthcare research field and/or pharmaceutical companies they are more in likely better to benefit from a patent (Shamoo & Resnik, 2009, p. 177). There are state laws in place to help protect trade secrets and others can be prosecuted if a competitor utilizes the trade secret (Shamoo & Resnik, 2009, p. 177). However, trade secrets seem to have minimal use within the healthcare research industry.
Trade Secrets:
…show more content…
177). Overall, former researchers and/or employers that know the trade secret may change jobs and disclose the information (Shamoo & Resnik, 2009, p. 177). In addition, the trade secrets could be accidently disclosed or the competitor can obtain the product and/or service and run their own tests on it to try to decipher the secret and provide a product with similar tastes, functions, and/or services (Shamoo & Resnik, 2009, p. 177). Therefore, researchers and/or pharmaceutical companies will least likely benefit from trade

Related Documents

  • Improved Essays

    George Fomum-Mugri MGMT 201 10/25/2016 Intellectual Property – Federal Trade Commission v. Actavis (2013) Summary: The case deals with an antitrust dispute of a progressively increasing practice within the pharmaceutical industry. Brand-name drug manufacturers, such as Solvay Pharmaceuticals and GlaxoSmithKline, challenged with the competition of generic drug manufacturers essentially bribe prospective competitors with cash payments incentivizing them to abstain from the market.…

    • 1014 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Bayh-Dole Act 1970

    • 796 Words
    • 4 Pages

    48 However, the Bayh-Dole Act has resulted in direct institutional ownership of parts of the intellectual property that protects many new drugs.49 To justify granting these private patent rights for government-sponsored inventions, one cannot use the typical innovation incentive of patents, because academic researchers have been innovating long before the Bayh-Dole Act and are primarily motivated by a desire for prestige.so Instead, Bayh-Dole patents typically are justified under commercialization theory-the idea that companies need exclusive patent rights to bring an invention to market." ' Commercialization theory is not appropriate for many industries, but exclusive rights may be needed in the pharmaceutical industry because of the high cost of FDA approval and low cost of…

    • 796 Words
    • 4 Pages
    Improved Essays
  • Superior Essays

    Crichton Vs Calfee

    • 929 Words
    • 4 Pages

    This causes concern for patients and researchers, although Calfee argues that in fact the gene patent can benefit both parties regardless of the gene patent holders pricing, stating “...like most economists I support the granting of patents and their consequent pricing power as a tool to foster innovation.” (para. 3). Another complaint Calfee mentions, was noted by an academic plaintiff who stated in the Times story Calfee pulls his argument from, concerning the hinderance of research stating “...potentially disastrous scenario is a “patent thicket” in which research is hemmed in by the possibility of bumping into all sorts of patents, such as those the researchers never knew existed.” (para. 4) which caused concern for “...legendary costs and delay”. Although Calfee quickly states how the National Academy of Science pursued two surveys, led by well qualified expert John Walsh, in which they found “...little evidence emerged that research laboratories were hemmed in by gene patents.”…

    • 929 Words
    • 4 Pages
    Superior Essays
  • Improved Essays

    ower to institute policies which restrict the use of specialty drugs and only giving priority to those who are in need. Increased efforts are also being instituted so as to provide research on the possible benefits and costs of specialty drugs with reports being expected on the newly approved high impact drugs. The reports will be responsible for the analysis of the drug’s effectiveness and the potential economic burden. Specialty Drug Policy Making…

    • 823 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    Over Medicated Essay

    • 512 Words
    • 3 Pages

    Last year, pharmacist filled 4,468,929,929 prescriptions in the United States that is an 85 percent increase from just twenty years earlier (Carr, Rabkin, and Skinner 38). With these kinds of numbers, it must be obvious the process to develop drugs in America is working like a well-oiled machine, or is it? Prescription drug companies, the Food and Drug Administration (FDA) and independent research companies including universities all work together to develop improved medications. Each one has an unbiased, independent role to play in the process, however, over the years the unbiased independent part has become blurred. The Federal Government has made changes to regulations and health care policies, consequently, the prescription drug company’s…

    • 512 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    How is the role of government likely to change? The role of the government will increase by supporting advance technology innovation across an extensive range of healthcare specialties. Sponsors of public and private healthcare segments will champion efforts to accelerate innovation and sustain advances in medical technology. As healthcare cost increase, federal funding should also increase for innovating healthcare IT infrastructure and promote science and research for more innovation.…

    • 1084 Words
    • 5 Pages
    Improved Essays
  • Great Essays

    Cost Of Healthcare

    • 1442 Words
    • 6 Pages

    Economic abuse creates mistrust of the healthcare industry. The pharmaceutical industry has lost the trust of the American people and it is doubtful that they will be able to win it back any time soon. Americans are frustrated, and rightly so, at the greed associated with medicine. “The pharmaceutical industry likes to depict itself as a research-based industry, as the source of innovative drugs.…

    • 1442 Words
    • 6 Pages
    Great Essays
  • Improved Essays

    i. The two companies that were selected are Pfizer and Johnson & Johnson. First of all, Pfizer, Inc. is a research-based, global biopharmaceutical company which it focuses in improving the health standards locally or globally by manufacturing vaccines and injectable biologic medicines. Basically Pfizer operates under a few business segments such as Global Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare and Global Established Pharmaceutical. Unlike Pfizer, Johnson & Johnson is an investment holding company which focuses its interest towards health care products.…

    • 826 Words
    • 4 Pages
    Improved Essays
  • Superior Essays

    Clinical trials have been performed at many sites around the world for many years to obtain approvals in multiple countries. The harmonization of regulatory processes developed by the ICH, drug patent laws, and country specific regulations is very important steps towards the product development, such as drug discovery, early development and preclinical testing, clinical trials and marketing authorizations. Nearly every country agrees to accept the ICH technical necessities for registration of pharmaceutical products for human use. Taking this into an account makes very easy to perform worldwide clinical trials by outsourcing and offshoring models to achieve the numerous regulatory and commercial incentives obtainable in many countries. The perfect time to build a regulatory strategy is before submitting an Investigational New Drug (IND) application.…

    • 1496 Words
    • 6 Pages
    Superior Essays
  • Great Essays

    esentation analyses the events leading up to the 2004 merger between the pharmaceutical companies Sanofi-Synthelabo and Aventis. It reveals the social, commercial and political complexities and challenges of a merger process in which the defence of French national interests and regional capabilities competed with traditional ‘commercial’ narratives before the deal was closed. presentation critically evaluates the competing criteria adopted by government and industry to justify different merger scenarios and considers the implications for pharmaceutical innovation, industry consolidation and M&A theory The American economy greatest market for the pharmaceutical industry in 2004 the tax cuts and the lower interest rates stimulated expansion…

    • 1499 Words
    • 6 Pages
    Great Essays
  • Improved Essays

    Assignment Unit 6 Question: 1. Each of the following firms possesses market power. Explain its source a) Merck, the producer of a patented cholesterol-lowering drug b) Aliant, a provider of a telephone service c) Chiquita, a banana supplier and owner of most banana plantations Answer to Question: a. Merck like most drug companies will have a patent for their cholesterol drug. The patent is essentially the legal rights to the formula for the drug and it prevents other companies from being able to copy/ produce the same drug Merck is producing.…

    • 589 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    Epipen Case Study

    • 1781 Words
    • 8 Pages

    It is estimated that there are currently 43 million Americans at risk of anaphylaxis, a life-threatening allergic reaction (“Mylan’s Commitment,” 2016). The majority of these people are in constant possession of an EpiPen, an auto-injector containing epinephrine used to reverse anaphylaxis (“Anaphylaxis,” 2016). However, in recent years the price of the EpiPen has increased substantially; a two-pack currently costs $609 (Pollack, 2016). Because Mylan commands around 85 percent of the epinephrine auto-injector market, almost all of those at risk have been affected (Herrick, 2016: 2). Concerns about drug price increases, like the EpiPen’s, have caused confusion in many people.…

    • 1781 Words
    • 8 Pages
    Great Essays
  • Superior Essays

    Many believe that the pharmaceutical industries are strictly a beneficial organization that concentrates on ways to provide new medicines to conclude individuals with outstanding health. It is also believed that these pharmaceutical industries provide honest knowledge to their upcoming student 's that currently intern that will soon be great pharmacists after school is finished. While this may be somewhat true there are some factual reasons why it is not strongly incorrect. Pharmaceutical industries do focus on studies to discover new medicine although more importantly to them they focus on advertisement and influence. More money is spent on advertisement to introduce and persuade these prescription medicines to the people of America than there is spent on research for new medicine.…

    • 2274 Words
    • 10 Pages
    Superior Essays
  • Improved Essays

    In this report the role of the government in pharmaceutical regulation will be explored. Examples of how the government regulates the pharmaceutical industry will be presented; furthermore, each event will be analysed to determine whether the regulation was from a public or private interest theory perspective. In the end the goal is to reveal the dominant theory of regulation in the industry and which theory better predicts the outcome of events presented. The government’s role in the pharmaceutical industry always starts with a regulatory body.…

    • 984 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    The core of the pharmaceutical industry problems consists of the expiration of patents, rising R&D expenses, and uncertainties facing new researched products and their abnormal methods of circulation of returns from said product. As rooted in the topic of this case AstraZeneca upholds the gold of innovatively changing the way medicine reaches patients. When patents are first granted there are procedures that followed before a drug reaches the marketplace. Due to the extended timeframe that is required for clinical trials, studies and organizational processes to tested and developed the revenue phase of the drug decreases (Hitt, Ireland, & Hoskisson, 2015). More specifically after the developed drug is ready for sale the patent remaining on these products are near expiration.…

    • 703 Words
    • 3 Pages
    Improved Essays